ACTU (Actuate Therapeutics) Institutional Ownership: 60.16% (As of Jul. 01, 2026)


ACTU Actuate Therapeutics Inc ACTU
14 GF Score
Price $1.46
View Full Analysis

What is Actuate Therapeutics Institutional Ownership?

Actuate Therapeutics ACTU -3.31% 14 Institutional Ownership is 60.16% as of Jul. 01, 2026. GuruFocus rates ACTU with a GF Score™ of 14/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Actuate Therapeutics's institutional ownership is 60.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Actuate Therapeutics's Insider Ownership is 1.16%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Actuate Therapeutics's Float Percentage Of Total Shares Outstanding is 43.77%.

Actuate Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Actuate Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Actuate Therapeutics Institutional Ownership Chart

Actuate Therapeutics Historical Data

The historical data trend for Actuate Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 4.33 4.44 4.86 5.35 7.16 7.09 7.12 6.68 6.66 6.72
ACTU
14GF Score
Actuate Therapeutics Inc ACTU
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Actuate Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 60.16% mean?
Actuate Therapeutics (ACTU) has a Institutional Ownership of 60.16% as of Jul. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Actuate Therapeutics and its competitors.
Is Actuate Therapeutics' Institutional Ownership too high?
Actuate Therapeutics' current Institutional Ownership is 60.16%. Overall, Actuate Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Actuate Therapeutics' Institutional Ownership compare to RNXT and ESLA?
Actuate Therapeutics' Institutional Ownership of 60.16% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Actuate Therapeutics and its competitors. Actuate Therapeutics's current Institutional Ownership is 60.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Actuate Therapeutics stock overvalued right now?
Actuate Therapeutics (ACTU) has a current Institutional Ownership of 60.16%. The current Institutional Ownership is 60.16%. Actuate Therapeutics' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Actuate Therapeutics (ACTU), the current Institutional Ownership is 60.16% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Actuate Therapeutics Business Description

Address 1751 River Run, Suite 400, Fort Worth, TX, USA, 76107
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
14GF Score

Get the complete analysis for ACTU

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price